Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-28

Clinical Trial Update: Darunavir and Rilpivirine Interactions With Levonorgestrel Implant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating interactions between darunavir/Rilpivirine and levonorgestrel implant for HIV-1 infection and contraception.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darunavir (darunavir)
  • levonorgestrel implant (levonorgestrel)
  • rilpivirine (rilpivirine)

Snippet

Sponsor: Makerere University | Conditions: HIV-1-infection, Contraception | Phase 2 | Status: UNKNOWN